Skip to main content

2 Result(s)

within **ao-Mo Wang Remove this filter Medicine & Public Health Remove this filter Hepatology Remove this filter

and

  1. Article

    Effectiveness and safety of 8-week glecaprevir/pibrentasvir in HCV treatment-naïve patients with compensated cirrhosis: real-world experience from Taiwan nationwide HCV registry

    Large-scale real-world data of the 8-week glecaprevir/pibrentasvir (GLE/PIB) therapy for treatment-naïve patients of chronic hepatitis C virus (HCV) infection with compensated cirrhosis is scarce.

    Te-Sheng Chang, Chung-Feng Huang, Hsing-Tao Kuo, Ching-Chu Lo… in Hepatology International (2023)

    Download PDF (650 KB) View Article

  2. No Access

    Article

    Liver stiffness measurement in the risk assessment of hepatocellular carcinoma for patients with chronic hepatitis

    The risk of hepatocellular carcinoma (HCC) increased with progression of hepatic fibrosis as assessed by liver stiffness measurement (LSM). This study used LSM to assess the risk of HCC presence in patients wi...

    Yuan-Hung Kuo, Sheng-Nan Lu, Chao-Hung Hung, Kwong-Ming Kee… in Hepatology International (2010)